ADIM
NOV icon

Alpha DNA Investment Management’s NOV NOV Stock Holding History

Alpha DNA Investment Management’s Portfolio NOV Stock Details NOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-58,747
Closed -$1.09M – 203
2023
Q1 		$1.09M Buy
+58,747
New +$1.27M 0.32% 80
2022
Q4 		– Sell
-40,396
Closed -$653K – 186
2022
Q3 		$653K Buy
+40,396
New +$679K 0.54% 74
2021
Q2 		– Sell
-389
Closed -$5K – 450
2021
Q1 		$5K Buy
+389
New +$5.64K 0.01% 370

Other funds holding NOV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Alpha DNA Investment Management's NOV Position: Q2 2023 in Review

Alpha DNA Investment Management sold out of NOV (NOV) in Q2 2023, closing a stake of 58,747 shares — an estimated $1.09M sold.

Alpha DNA Investment Management first reported a position in NOV in Q1 2021 and held it in 3 quarters. The position peaked at $1.09M in Q1 2023. 366 funds tracked by Wall St. Rank hold NOV as of Q2 2023.

  • Alpha DNA Investment Management reported no remaining NOV position as of Q2 2023 after selling out during the quarter.
  • Alpha DNA Investment Management sold 58,747 NOV shares in Q2 2023, an estimated $1.09M.
  • Alpha DNA Investment Management first reported a position in NOV in Q1 2021 and held it in 3 quarters.
  • Alpha DNA Investment Management's NOV position peaked at $1.09M in Q1 2023.
  • 366 funds tracked by Wall St. Rank held NOV as of Q2 2023.

Based on Alpha DNA Investment Management's 13F filing for Q2 2023, filed 31 Jul 2023.